Trinity Life Sciences’ Managing Director and Head of Value Center of Excellence, Mary Fletcher-Louis, spoke with Access Insider about how the UK’s National Institute for Health and Care Excellence (NICE) is spearheading a global shift in pharmaceutical decision-making by incorporating health equity considerations into drug submissions.